COMMUNIQUÉS West-GlobeNewswire

Beta Bionics Announces Participation at Upcoming Investor Conferences
21/08/2025
IRVINE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at [...]
Valitor Announces Upcoming Presentations at the Ophthalmology Futures Retina Forum and Euretina Conference, Including New Data for its Long-Acting Anti-VEGF Drug Candidate for Wet AMD, VLTR-559
21/08/2025
New non-human primate (NHP) data for VLTR-559, a long-acting anti-VEGF therapy that could reduce the dosing frequency for the treatment of wet age-related macular degeneration (AMD) to twice-yearly, will be presented [...]
UroGen Pharma to Present at Upcoming Investor Conferences
21/08/2025
PRINCETON, N.J., Aug. 21, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today [...]
Immuneering Announces $25 Million Private Placement
21/08/2025
CAMBRIDGE, Mass., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced that it has entered into a [...]
Catheter Precision Announces the Start of Enrollment for the LockeT Compare Study
21/08/2025
First patients have been enrolled Fort Mill, S.C., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced [...]
VeonGen Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for VG801 Gene Therapy for Stargardt Disease
21/08/2025
MUNICH, Aug. 21, 2025 (GLOBE NEWSWIRE) -- VeonGen Therapeutics, a clinical-stage genetic medicine company developing next-generation gene therapies, today announced that the U.S. Food and Drug Administration (FDA) has [...]
Cue Biopharma to Participate in Fireside Chat at the Cantor Global Healthcare Conference
21/08/2025
BOSTON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease- [...]
Beacon Therapeutics Announces EURETINA 2025 Presentations on 9+-Month Phase 2 DAWN and 36-Month Phase 2 SKYLINE Trial Data for laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP)
21/08/2025
LONDON and CAMBRIDGE, Mass., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading clinical-stage biotechnology company with a mission to save and [...]
Cube Biotech and X-Chem Partner to Enable DNA-encoded Library Screening of NativeMP™-stabilized Membrane Proteins
21/08/2025
MONHEIM, Germany and Waltham, Mass. , Aug. 21, 2025 (GLOBE NEWSWIRE) -- Cube Biotech, a pioneer in membrane protein stabilization and purification, and X-Chem, the global leader in DNA-Encoded Library (DEL) technology [...]
Sienna Announces Completion of $175 Million Offering of 4.112% Series E Senior Unsecured Debentures
21/08/2025
NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MARKHAM, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) [...]
Quoin Pharmaceuticals’ NETHERTON NOW Campaign Surpasses One Million Video Views, Amplifying Global Awareness of Netherton Syndrome
21/08/2025
ASHBURN, Va., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today [...]
581 100 $ récoltés pour de l’équipement d’imagerie médicale à la fine pointe lors du Tournoi de golf annuel de l’Hôpital Shriners du Canada
21/08/2025
MONTRÉAL, 21 août 2025 (GLOBE NEWSWIRE) -- Le 14e tournoi de golf annuel de l’Hôpital Shriners pour enfants Canada, qui s’est tenu le 7 août 2025 au Summerlea Golf and Country Club , a réuni 252 golfeurs, 47 bénévoles, [...]
Shriners Hospitals for Children Canada golf tournament raises $581,100 for state-of-the-art medical imaging equipment
21/08/2025
MONTREAL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The 14th annual Shriners Hospitals for Children Canada Golf Tournament, held on August 7, 2025 at Summerlea Golf and Country Club , united 252 golfers, 47 volunteers, generous [...]
ICU Medical to Participate in Upcoming Investor Conferences
21/08/2025
SAN CLEMENTE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following [...]
60 Degrees Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference
21/08/2025
WASHINGTON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne [...]
AMPS to Spotlight ClaimInsight at CAHP 2025, Delivering a Smarter Future for Payment Integrity in California
21/08/2025
PHOENIX, Aug. 21, 2025 (GLOBE NEWSWIRE) -- As the California healthcare system faces unprecedented financial strain and legislative complexity, Advanced Medical Pricing Solutions (AMPS) will bring a powerful cost [...]
Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)
21/08/2025
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for atumelnant, a novel [...]
Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™
21/08/2025
GAITHERSBURG, Md., Aug. 21, 2025 (GLOBE NEWSWIRE) -- As opioid emergencies continue to be the leading cause of accidental death in the United States, 1 Emergent BioSolutions (NYSE: EBS) is teaming up with Voices for [...]
Parexel Appoints Biotech Business Head Jim Anthony to Expanded Role as Chief Commercial Officer and President, Parexel Biotech
21/08/2025
Strategic leadership appointment strengthens company’s commercial approach to drive continued growth and deliver long-term value DURHAM, N.C., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical [...]

Pages